Is Cosmos Health Stock a Good Investment?
Cosmos Health Investment Advice | COSM |
- Examine Cosmos Health's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Cosmos Health's leadership team and their track record. Good management can help Cosmos Health navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Providers & Services space and any emerging trends that could impact Cosmos Health's business and its evolving consumer preferences.
- Compare Cosmos Health's performance and market position to its competitors. Analyze how Cosmos Health is positioned in terms of product offerings, innovation, and market share.
- Check if Cosmos Health pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Cosmos Health's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Cosmos Health stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Cosmos Health is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Dangerous | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | About Average | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Cosmos Health Stock
Researching Cosmos Health's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 16.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.5. Some equities with similar Price to Book (P/B) outperform the market in the long run. Cosmos Health recorded a loss per share of 2.45. The entity last dividend was issued on the 21st of November 2017. The firm had 1:10 split on the 21st of November 2017.
To determine if Cosmos Health is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Cosmos Health's research are outlined below:
| Cosmos Health generated a negative expected return over the last 90 days | |
| Cosmos Health has some characteristics of a very speculative penny stock | |
| Cosmos Health has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 53.38 M. Net Loss for the year was (18.54 M) with profit before overhead, payroll, taxes, and interest of 8.33 M. | |
| Cosmos Health currently holds about 322.37 K in cash with (15.64 M) of positive cash flow from operations. | |
| Cosmos Health has a frail financial position based on the latest SEC disclosures | |
| Roughly 16.0% of the company shares are held by company insiders | |
| Latest headline from finance.yahoo.com: Taglich Brothers Releases Updated Coverage on Cosmos Health Projects Positive EPS for 2025 and Sets 3 Price Target, Nearly 300 percent Above Current Share Price |
Cosmos Health uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Cosmos Health. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Cosmos Health's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 11th of April 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Earnings surprises can significantly impact Cosmos Health's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Cosmos Health's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-04-12 | 2024-03-31 | -0.14 | -0.11 | 0.03 | 21 | ||
2024-11-18 | 2024-09-30 | -0.11 | -0.45 | -0.34 | 309 | ||
2023-12-31 | 2023-12-31 | -0.2 | -1.6982 | -1.4982 | 749 |
Know Cosmos Health's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Cosmos Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Cosmos Health backward and forwards among themselves. Cosmos Health's institutional investor refers to the entity that pools money to purchase Cosmos Health's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Cornerstone Planning Group Llc | 2024-09-30 | 200 | Bank Of America Corp | 2024-06-30 | 122 | Wells Fargo & Co | 2024-06-30 | 0.0 | Fmr Inc | 2024-06-30 | 0.0 | Compagnie Lombard, Odier Sca | 2024-06-30 | 0.0 | Hrt Financial Llc | 2024-06-30 | 0.0 | Armistice Capital, Llc | 2024-09-30 | 1.7 M | Blackrock Inc | 2024-06-30 | 267.8 K | Geode Capital Management, Llc | 2024-09-30 | 149.7 K | Vanguard Group Inc | 2024-09-30 | 134.8 K | State Street Corp | 2024-06-30 | 24.7 K |
Cosmos Health's market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 18.33 M.Market Cap |
|
Cosmos Health's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.32) | (0.33) | |
| Return On Capital Employed | (0.52) | (0.50) | |
| Return On Assets | (0.28) | (0.29) | |
| Return On Equity | (0.51) | (0.49) |
Determining Cosmos Health's profitability involves analyzing its financial statements and using various financial metrics to determine if Cosmos Health is a good buy. For example, gross profit margin measures Cosmos Health's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Cosmos Health's profitability and make more informed investment decisions.
Evaluate Cosmos Health's management efficiency
Cosmos Health has return on total asset (ROA) of (0.2023) % which means that it has lost $0.2023 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5661) %, meaning that it created substantial loss on money invested by shareholders. Cosmos Health's management efficiency ratios could be used to measure how well Cosmos Health manages its routine affairs as well as how well it operates its assets and liabilities. As of the 28th of November 2024, Return On Tangible Assets is likely to drop to -0.33. In addition to that, Return On Capital Employed is likely to grow to -0.5. At this time, Cosmos Health's Asset Turnover is very stable compared to the past year.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 3.01 | 3.16 | |
| Tangible Book Value Per Share | 2.37 | 2.49 | |
| Enterprise Value Over EBITDA | (1.49) | (1.57) | |
| Price Book Value Ratio | 0.47 | 0.49 | |
| Enterprise Value Multiple | (1.49) | (1.57) | |
| Price Fair Value | 0.47 | 0.49 | |
| Enterprise Value | 25.5 M | 22.7 M |
Leadership at Cosmos Health emphasizes sustainable growth and financial prudence. Our analysis evaluates how these priorities impact the stock's performance in the market.
Beta 3.142 |
Basic technical analysis of Cosmos Stock
As of the 28th of November, Cosmos Health shows the Risk Adjusted Performance of (0.07), standard deviation of 4.85, and Mean Deviation of 3.72. Cosmos Health technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Cosmos Health market risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and skewness to decide if Cosmos Health is priced correctly, providing market reflects its regular price of 0.81 per share. Given that Cosmos Health is a hitting penny stock territory we recommend to closely look at its jensen alpha.Cosmos Health's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Cosmos Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Cosmos Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Cosmos Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Cosmos Health's Outstanding Corporate Bonds
Cosmos Health issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Cosmos Health uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Cosmos bonds can be classified according to their maturity, which is the date when Cosmos Health has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View |
Understand Cosmos Health's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Cosmos Health's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.07) | |||
| Market Risk Adjusted Performance | (0.86) | |||
| Mean Deviation | 3.72 | |||
| Coefficient Of Variation | (963.85) | |||
| Standard Deviation | 4.85 | |||
| Variance | 23.5 | |||
| Information Ratio | (0.13) | |||
| Jensen Alpha | (0.58) | |||
| Total Risk Alpha | (1.28) | |||
| Treynor Ratio | (0.87) | |||
| Maximum Drawdown | 27.64 | |||
| Value At Risk | (7.89) | |||
| Potential Upside | 6.85 | |||
| Skewness | 0.2464 | |||
| Kurtosis | 0.877 |
| Risk Adjusted Performance | (0.07) | |||
| Market Risk Adjusted Performance | (0.86) | |||
| Mean Deviation | 3.72 | |||
| Coefficient Of Variation | (963.85) | |||
| Standard Deviation | 4.85 | |||
| Variance | 23.5 | |||
| Information Ratio | (0.13) | |||
| Jensen Alpha | (0.58) | |||
| Total Risk Alpha | (1.28) | |||
| Treynor Ratio | (0.87) | |||
| Maximum Drawdown | 27.64 | |||
| Value At Risk | (7.89) | |||
| Potential Upside | 6.85 | |||
| Skewness | 0.2464 | |||
| Kurtosis | 0.877 |
Consider Cosmos Health's intraday indicators
Cosmos Health intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Cosmos Health stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Cosmos Health time-series forecasting models is one of many Cosmos Health's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Cosmos Health's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Cosmos Stock media impact
Far too much social signal, news, headlines, and media speculation about Cosmos Health that are available to investors today. That information is available publicly through Cosmos media outlets and privately through word of mouth or via Cosmos internal channels. However, regardless of the origin, that massive amount of Cosmos data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Cosmos Health news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Cosmos Health relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Cosmos Health's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Cosmos Health alpha.
Cosmos Health Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Cosmos Health can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
When determining whether Cosmos Health is a strong investment it is important to analyze Cosmos Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Cosmos Health's future performance. For an informed investment choice regarding Cosmos Stock, refer to the following important reports: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cosmos Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. To learn how to invest in Cosmos Stock, please use our How to Invest in Cosmos Health guide.You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cosmos Health. If investors know Cosmos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cosmos Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.45) | Revenue Per Share 3.733 | Quarterly Revenue Growth 0.068 | Return On Assets (0.20) | Return On Equity (0.57) |
The market value of Cosmos Health is measured differently than its book value, which is the value of Cosmos that is recorded on the company's balance sheet. Investors also form their own opinion of Cosmos Health's value that differs from its market value or its book value, called intrinsic value, which is Cosmos Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cosmos Health's market value can be influenced by many factors that don't directly affect Cosmos Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Cosmos Health's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Cosmos Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cosmos Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.